Commonwealth Retirement Investments LLC Acquires New Shares in VanEck Biotech ETF (NASDAQ:BBH)

Commonwealth Retirement Investments LLC bought a new position in shares of VanEck Biotech ETF (NASDAQ:BBH) during the 4th quarter, HoldingsChannel reports. The firm bought 1,372 shares of the company’s stock, valued at approximately $215,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Strategic Financial Concepts LLC purchased a new stake in shares of VanEck Biotech ETF in the 4th quarter worth approximately $3,828,000. Jane Street Group LLC raised its stake in VanEck Biotech ETF by 401.7% in the third quarter. Jane Street Group LLC now owns 8,348 shares of the company’s stock worth $1,481,000 after buying an additional 6,684 shares in the last quarter. Kovitz Investment Group Partners LLC lifted its holdings in VanEck Biotech ETF by 4.6% during the third quarter. Kovitz Investment Group Partners LLC now owns 3,186 shares of the company’s stock worth $565,000 after buying an additional 141 shares during the period. Janney Montgomery Scott LLC bought a new stake in VanEck Biotech ETF during the 4th quarter valued at $481,000. Finally, Flagship Harbor Advisors LLC increased its holdings in shares of VanEck Biotech ETF by 12.1% in the 4th quarter. Flagship Harbor Advisors LLC now owns 1,984 shares of the company’s stock valued at $311,000 after acquiring an additional 214 shares during the period. 32.05% of the stock is currently owned by institutional investors.

VanEck Biotech ETF Stock Performance

Shares of NASDAQ BBH opened at $166.16 on Tuesday. VanEck Biotech ETF has a 1-year low of $151.35 and a 1-year high of $183.64. The business has a fifty day moving average price of $161.19 and a 200 day moving average price of $169.28.

VanEck Biotech ETF Dividend Announcement

The company also recently declared a dividend, which was paid on Tuesday, December 24th. Shareholders of record on Monday, December 23rd were given a dividend of $1.2517 per share. The ex-dividend date of this dividend was Monday, December 23rd.

VanEck Biotech ETF Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.